ArticleActa pharmaceutica Sinica. B2022

Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy.

Xiaohong Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.